Leena Vilpo

783 total citations
39 papers, 610 citations indexed

About

Leena Vilpo is a scholar working on Genetics, Immunology and Molecular Biology. According to data from OpenAlex, Leena Vilpo has authored 39 papers receiving a total of 610 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Genetics, 19 papers in Immunology and 11 papers in Molecular Biology. Recurrent topics in Leena Vilpo's work include Chronic Lymphocytic Leukemia Research (24 papers), Immunodeficiency and Autoimmune Disorders (17 papers) and Lymphoma Diagnosis and Treatment (11 papers). Leena Vilpo is often cited by papers focused on Chronic Lymphocytic Leukemia Research (24 papers), Immunodeficiency and Autoimmune Disorders (17 papers) and Lymphoma Diagnosis and Treatment (11 papers). Leena Vilpo collaborates with scholars based in Finland, Sweden and Poland. Leena Vilpo's co-authors include Juhani Vilpo, Mikko Hurme, Janne Hulkkonen, Sakari Knuutila, Ritva Karhu, Wael El‐Rifai, Risto Aine, Bálint Nagy, Yan Aalto and Mauno Vihinen and has published in prestigious journals such as Molecular and Cellular Biology, Analytical Biochemistry and Clinical Orthopaedics and Related Research.

In The Last Decade

Leena Vilpo

39 papers receiving 590 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Leena Vilpo 322 226 226 205 121 39 610
Laia Rosich 162 0.5× 151 0.7× 121 0.5× 410 2.0× 134 1.1× 21 721
Vicente Fresquet 154 0.5× 132 0.6× 105 0.5× 442 2.2× 166 1.4× 24 703
Gábor Barna 119 0.4× 92 0.4× 153 0.7× 387 1.9× 173 1.4× 64 711
Mercè de Frías 184 0.6× 94 0.4× 103 0.5× 511 2.5× 237 2.0× 17 734
Beth Fischer 426 1.3× 309 1.4× 161 0.7× 298 1.5× 328 2.7× 28 829
Swaroop Vakkalanka 266 0.8× 244 1.1× 131 0.6× 210 1.0× 132 1.1× 46 551
Elisabeth Walsby 131 0.4× 94 0.4× 83 0.4× 308 1.5× 216 1.8× 25 559
Matthew J. Saabye 85 0.3× 56 0.2× 159 0.7× 267 1.3× 190 1.6× 8 703
Paweł Robak 343 1.1× 269 1.2× 186 0.8× 539 2.6× 372 3.1× 86 1.1k

Countries citing papers authored by Leena Vilpo

Since Specialization
Citations

This map shows the geographic impact of Leena Vilpo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leena Vilpo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leena Vilpo more than expected).

Fields of papers citing papers by Leena Vilpo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leena Vilpo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leena Vilpo. The network helps show where Leena Vilpo may publish in the future.

Co-authorship network of co-authors of Leena Vilpo

This figure shows the co-authorship network connecting the top 25 collaborators of Leena Vilpo. A scholar is included among the top collaborators of Leena Vilpo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leena Vilpo. Leena Vilpo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kazimierczuk, Zygmunt, Mariola Kozłowska, Stanisław J. Chrapusta, et al.. (2007). Two novel nucleoside ester derivatives of chlorambucil as potential antileukemic prodrugs: a preliminary study. Anti-Cancer Drugs. 18(3). 301–310. 6 indexed citations
2.
Vilpo, Juhani, Gerard Tobin, Janne Hulkkonen, et al.. (2005). Mitogen induced activation, proliferation and surface antigen expression patterns in unmutated and hypermutated chronic lymphocytic leukemia cells. European Journal Of Haematology. 75(1). 34–40. 3 indexed citations
3.
Kazimierczuk, Zygmunt, Jan K. Maurin, Agnieszka E. Laudy, et al.. (2004). Novel adamantylated pyrimidines and their preliminary biological evaluations. Il Farmaco. 59(12). 929–937. 21 indexed citations
4.
Vilpo, Juhani, Gerard Tobin, Janne Hulkkonen, et al.. (2003). Surface antigen expression and correlation with variable heavy‐chain gene mutation status in chronic lymphocytic leukemia. European Journal Of Haematology. 70(1). 53–59. 19 indexed citations
5.
Karhu, Ritva, Leena Vilpo, Jorma Isola, Sakari Knuutila, & Juhani Vilpo. (2002). Cryopreserved chronic lymphocytic leukemia cells analyzed by multicolor fluorescence in situ hybridization after optimized mitogen stimulation. Genes Chromosomes and Cancer. 34(3). 345–348. 5 indexed citations
6.
Vilpo, Juhani, Janne Hulkkonen, Mikko Hurme, & Leena Vilpo. (2002). Surface membrane antigen expression changes induced in vitro by exogenous growth factors in chronic lymphocytic leukemia cells. Leukemia. 16(9). 1691–1698. 8 indexed citations
7.
Kivekäs, Ilkka, Leena Vilpo, & Juhani Vilpo. (2002). Relationships of in vitro sensitivities tested with nine drugs and two types of irradiation in chronic lymphocytic leukemia. Leukemia Research. 26(11). 1035–1041. 8 indexed citations
8.
Aalto, Yan, Wael El‐Rifai, Leena Vilpo, et al.. (2001). Distinct gene expression profiling in chronic lymphocytic leukemia with 11q23 deletion. Leukemia. 15(11). 1721–1728. 65 indexed citations
9.
Vilpo, Juhani, et al.. (2000). Selective toxicity of vincristine against chronic lymphocytic leukemia cells in vitro. European Journal Of Haematology. 65(6). 370–378. 26 indexed citations
10.
Karhu, Ritva, et al.. (2000). Complex chromosomal aberrations in chronic lymphocytic leukemia are associated with cellular drug and irradiation resistance. European Journal Of Haematology. 65(1). 32–39. 12 indexed citations
11.
Aine, Risto, et al.. (2000). Cyclosporin A-induced cell kill in vitro in various clinical-hematological types of B-cell chronic lymphocytic leukemia. Leukemia Research. 24(10). 805–812. 6 indexed citations
13.
Zhu, Ying, Outi Monni, Wael El‐Rifai, et al.. (1999). Discontinuous deletions at 11q23 in B cell chronic lymphocytic leukemia. Leukemia. 13(5). 708–712. 28 indexed citations
15.
Vilpo, Juhani, Leena Vilpo, Mikko Hurme, & Pauli Vuorinen. (1999). Induction of beta-2-microglobulin release in vitro by chronic lymphocytic leukaemia cells: relation to total protein synthesis. Leukemia Research. 23(10). 913–920. 10 indexed citations
16.
Aittoniemi, Janne, A Miettinen, Marjatta Sinisalo, et al.. (1999). Opsonising Immunoglobulins and Mannan-Binding Lectin in Chronic Lymphocytic Leukemia. Leukemia & lymphoma. 34(3-4). 381–385. 21 indexed citations
17.
Larramendy, Marcelo L., Yifang Zhu, Mikko Hurme, et al.. (1998). Optimized mitogen stimulation induces proliferation of neoplastic B cells in chronic lymphocytic leukemia: significance for cytogenetic analysis. Cytogenetic and Genome Research. 82(3-4). 215–221. 18 indexed citations
18.
Hulkkonen, Janne, et al.. (1998). Diminished production of interleukin‐6 in chronic lymphocytic leukaemia (B‐CLL) cells from patients at advanced stages of disease. British Journal of Haematology. 100(3). 478–483. 20 indexed citations
19.
Vilpo, Juhani & Leena Vilpo. (1995). Prevention of DNA 5-methylcytosine reutilization in human cells. Somatic Cell and Molecular Genetics. 21(4). 285–288. 6 indexed citations
20.
Vilpo, Leena, et al.. (1989). Time-resolved fluoroimmunoassay of 5-methyl-2′-deoxycytidine employing europium-labeled antigen as tracer. Journal of Immunological Methods. 117(1). 33–38. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026